There were 390 press releases posted in the last 24 hours and 150,508 in the last 365 days.

The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of AMPE, OPK and HTHT

NEW YORK, Oct. 12, 2018 (GLOBE NEWSWIRE) -- The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. If you suffered a loss you have until the lead plaintiff deadline to request that the court appoint you as lead plaintiff.        

/EIN News/ -- Ampio Pharmaceuticals, Inc. (NYSE American: AMPE)
Class Period: December 14, 2017 to August 7, 2018
Lead Plaintiff Deadline: October 24, 2018

The lawsuit alleges Ampio Pharmaceuticals, Inc. made materially false and/or misleading statements and/or failed to disclose during the class period that: (1) the FDA would find Ampio's AP-003-C Phase 3 clinical trial inadequate and not well-controlled; (2) as a result, Ampio had not successfully completed two pivotal clinical trials for Ampio; (3) consequently, Defendants' public statements were materially false and misleading at all relevant times.

Get additional information about the AMPE lawsuit: http://www.kleinstocklaw.com/pslra-1/ampio-pharmaceuticals-inc-loss-form?wire=3 

OPKO Health Inc. (NASDAQ: OPK)
Class Period: September 26, 2013 to September 7, 2018
Lead Plaintiff Deadline: November 13, 2018

The lawsuit alleges that throughout the class period, OPKO Health Inc. made materially false and/or misleading statements and/or failed to disclose that: (1) OPKO and its Chairman and Chief Executive Officer, Phillip Frost, were engaged in a pump-and-dump scheme with several other individuals and companies in their investments in several penny stocks; (2) this illicit scheme would result in governmental scrutiny including from the SEC; and (3) as a result, defendants’ statements about OPKO’s business, operations and prospects were materially false and misleading and/or lacked a reasonable basis at all relevant times.

Get additional information about the OPK lawsuit: http://www.kleinstocklaw.com/pslra-1/opko-health-inc-loss-submission-form?wire=3 

Huazhu Group Limited (NASDAQ: HTHT)
Class Period: May 14, 2018 to August 28, 2018
Lead Plaintiff Deadline: December 7, 2018

Throughout the class period, Huazhu Group Limited allegedly made materially false and/or misleading statements and/or failed to disclose that: (1) the Company lacked adequate security measures to protect customer information; (2) as a result of the foregoing, the Company would be susceptible to increased litigation risk and higher expenses; (3) as a result of the foregoing, the Company’s goodwill would potentially suffer, leading to lower revenues; and (4) as a result of the foregoing, Defendants’ positive statements about the Company’s business, operations, and prospects were materially false and/or misleading and/or lacked a reasonable basis.

Get additional information about the HTHT lawsuit: http://www.kleinstocklaw.com/pslra-1/huazhu-group-limited-loss-submission-form?wire=3 

Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff. There is no cost or obligation to you. If you suffered a loss during the class period and wish to obtain additional information, please contact Joseph Klein, Esq. by telephone at 212-616-4899 or visit the webpages provided.

Joseph Klein, Esq. represents investors and participates in securities litigations involving financial fraud throughout the nation. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:
Joseph Klein, Esq.
Empire State Building
350 Fifth Avenue
59th Floor
New York, NY 10118
jk@kleinstocklaw.com
Telephone: (212) 616-4899
Fax: (347) 558-9665
www.kleinstocklaw.com 

Klein NEW logo black transparent.png

Distribution channels: Consumer Goods, Law


EIN Presswire does not exercise editorial control over third-party content provided, uploaded, published, or distributed by users of EIN Presswire. We are a distributor, not a publisher, of 3rd party content. Such content may contain the views, opinions, statements, offers, and other material of the respective users, suppliers, participants, or authors.